SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,807.5 Cr | 20.6% | 22.6% | -2.6% | Stock Analytics | |
| SAGILITY INDIA | ₹19,708.4 Cr | -0.8% | 7.9% | 1.5% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,309.0 Cr | 1.3% | 1.5% | -47.3% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,117.7 Cr | -1.7% | -3% | -20.5% | Stock Analytics | |
| JUST DIAL | ₹4,943.7 Cr | 12% | 10.2% | -32% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,297.2 Cr | 17.8% | 26.3% | -53.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 20.6% |
22.6% |
-2.6% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses